Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

5.000 +0.220 (+4.60%)
Streaming Delayed Price Updated: 9:37 AM EDT, Jun 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday ↗
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
News headline image
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
From MacroGenics, Inc.
Via GlobeNewswire
7 Analysts Have This to Say About Macrogenics ↗
 
Via Benzinga
Expert Ratings for Macrogenics ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Macrogenics ↗
 
Via Benzinga
Where Macrogenics Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Shares of MacroGenics Were Dropping Tuesday ↗
Profit-taking and an analyst downgrade affected the stock's price. 
Via The Motley Fool
News headline image
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56% ↗
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday. 
Via Benzinga
News headline image
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
News headline image
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch ↗
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching. 
Via Investor's Business Daily
News headline image
Dow Jumps Over 300 Points; S&P 500 Rises 1% ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday. 
Via Benzinga
News headline image
MacroGenics (MGNX) Q3 2022 Earnings Call Transcript ↗
MGNX earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
News headline image
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
US Stocks Open Higher As Dow Surges 250 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday. 
Via Benzinga
News headline image
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles ↗
 
Via Benzinga
News headline image
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
Why MacroGenics Stock Crushed the Market on Monday ↗
Positive momentum continues for the cancer specialist in the wake of its latest earnings report. 
Via The Motley Fool
News headline image
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences ↗
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares... 
Via Benzinga
News headline image
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock ↗
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are... 
Via Benzinga
News headline image
Why MacroGenics Stock Popped Again Today ↗
Investors and analysts alike are getting more bullish on the company in the wake of its third-quarter results. 
Via The Motley Fool
News headline image
Why MacroGenics Stock Blasted Higher Today ↗
A quarter that was far better than expected gets investors excited about the biotech at the end of the week. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗
Gainers 
Via Benzinga
News headline image
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.